clonidine has been researched along with Autism Spectrum Disorder in 3 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clonidine was the most common medication to be used and was well tolerated." | 1.48 | Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India. ( Chandrasekaran, V; Kandasamy, P; Kuppili, PP; Manohar, H; Rajkumar, RP, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zammit, J | 3 |
| Ferrafiat, V | 3 |
| Naguy, A | 1 |
| Manohar, H | 1 |
| Kuppili, PP | 1 |
| Kandasamy, P | 1 |
| Chandrasekaran, V | 1 |
| Rajkumar, RP | 1 |
3 other studies available for clonidine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spect | 2017 |
Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Autism Spectrum | 2018 |